Chemoinformaics analysis of Decyl isobutyrate
| Molecular Weight | 228.376 | nRot | 10 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 1 |
| Exact Molecular Weight | 228.209 | nRing | 0 |
| Solubility: LogS | -5.539 | nHRing | 0 |
| Solubility: LogP | 5.558 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.6542 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.411 |
| Synth | 1.837 |
| Natural Product Likeliness | 0.354 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.063 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.532 |
| MDCK | 0.0000195 |
| BBB | 0.45 |
| PPB | 0.945807 |
| VDSS | 1.079 |
| FU | 0.0522137 |
| CYP1A2-inh | 0.862 |
| CYP1A2-sub | 0.376 |
| CYP2c19-inh | 0.663 |
| CYP2c19-sub | 0.401 |
| CYP2c9-inh | 0.438 |
| CYP2c9-sub | 0.847 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.241 |
| CYP3a4-sub | 0.147 |
| CL | 5.306 |
| T12 | 0.24 |
| hERG | 0.128 |
| Ames | 0.005 |
| ROA | 0.051 |
| SkinSen | 0.839 |
| Carcinogencity | 0.106 |
| EI | 0.981 |
| Respiratory | 0.643 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.726521 |